Trial | NCT00449397  Report issue

Title

Dose Finding of Quetiapine Fumarate 200mg vs 400mg in First Episode Psychosis
A Naturalistic, Prospective, Single Centre, Double Blinded, Fixed Dose, Randomised, Four Week Comparison Study Investigating Efficacy, Tolerability and Safety of 200 mg Per Day Versus 400 mg Per Day Quetiapine Fumarate in 200 Drug naïve First Episode Psychosis Patients Aged 15 to 25 Years.

  • Phase

    Phase 3

  • Study Type

    Interventional

  • Status

    Completed No Results Posted

  • Intervention/Treatment

    quetiapine ...

  • Study Participants

    150
The purpose of this study is determine the minimal effective dose and the impact on:

treatment outcomes at 4, 12 and/or 48 weeks the treatment has required to treat patients experiencing the first psychotic episode
the final maintenance doses
the use of other medications
the amount of changes to other antipsychotic medication
the number of hospitalization days
Study Started
Jul 31
2003
Primary Completion
Jan 31
2006
Study Completion
Jan 31
2006
Last Update
Jan 27
2011
Estimate

Drug Quetiapine Fumarate

Criteria 

Inclusion Criteria:

Patients experiencing their first psychotic episode
Male or Female
Aged 15-25

Exclusion Criteria:

Previous treatment with antipsychotic medication (longer than 1 week)
History of a clinically significant physical illness
Organic disorder presenting with psychotic symptoms
No Results Posted